Pulmonary Valve Stenosis

Valvular pulmonary stenosis (PS) is obstruction to right ventricular outflow at the level of the pulmonary valve itself, accounting for up to roughly a twelfth of all congenital cardiac malformations — its most common substrate by far is the valve leaflets themselves, though obstruction can also occur at subvalvular (infundibular) or supravalvular/peripheral levels, which need to be distinguished from true valvular disease.

Two Morphologic Substrates, Two Different Treatment Implications

Isolated valvular PS in children is most commonly a trifoliate, dome-shaped valve — leaflets fused from the periphery toward the center, forming a dome with a central orifice (an eccentric, unicommissural “keyhole” orifice of the kind seen in some stenotic aortic valves is exceedingly rare in the pulmonary position). This fused, domed morphology is the pattern most amenable to surgical division or balloon dilation — the fused commissures simply need to be opened.

A genuinely different substrate is the dysplastic valve: thickened, irregular, “cauliflower-like” leaflets with poor mobility from mucoid dysplastic change, rather than simple commissural fusion. This pattern is specifically associated with Noonan syndrome, and — this is the clinically important consequence — dysplastic valves respond less well to balloon valvuloplasty than fused, doming valves, often requiring surgical intervention instead. Recognizing which substrate is present isn’t just descriptive; it changes the recommended first-line treatment.

Congenital supravalvar pulmonary stenosis is also commonly seen in Noonan syndrome — worth knowing that Noonan syndrome’s association with pulmonary valve disease operates at more than one level (dysplastic valvular disease and supravalvar narrowing), not just one or the other. Careful imaging is needed to distinguish a doming valve from a discrete supravalvar membrane or narrowing at the sinotubular junction, since the distinction can genuinely be difficult and has different management implications.

Etiology

• Congenital — the dominant cause overall, via either commissural fusion (doming valve) or dysplasia, as above.
• Carcinoid heart disease — right-sided valves are preferentially affected because vasoactive substances (chiefly serotonin) are normally inactivated in the lungs, sparing the left heart in most cases; left-sided involvement occurs in roughly 15% of cases, typically with a right-to-left shunt, bronchial carcinoid, or very high tumor burden allowing vasoactive substances to bypass pulmonary inactivation. The tricuspid valve is affected most often, with the pulmonary valve next most common — plaque-like fibrous deposits restrict the orifice and can produce both stenosis and regurgitation together. A 24-hour urine 5-HIAA (a serotonin metabolite) level of 300 μmol or greater is an independent predictor of carcinoid heart disease development or progression.
• Rheumatic heart disease — an uncommon cause of pulmonic valve involvement specifically, in contrast to its dominant role on the left side.

A Genuine Diagnostic Pitfall: Underestimating Severity

Pulmonary stenosis severity can be significantly underestimated in the setting of severe tricuspid regurgitation or otherwise reduced cardiac output — with less flow crossing the valve, the measured gradient falls even though the anatomic orifice hasn’t changed, the same low-flow phenomenon that complicates aortic stenosis grading. This is worth checking for deliberately whenever significant TR coexists with PS, rather than taking a measured gradient at face value.

A second, different pitfall applies specifically to young infants: mild bilateral branch pulmonary artery narrowing is often a normal, “physiologic” finding at this age from relative hypoplasia, and shouldn’t be over-called as pathologic peripheral pulmonic stenosis without correlating against the clinical picture.

Pathophysiology

Valve obstruction increases RV systolic workload, driving right ventricular hypertrophy; with more severe or long-standing obstruction, right atrial pressure rises and the atrium enlarges as well. The high-velocity jet through the stenotic orifice mechanically stresses the low-resistance, high-compliance wall of the main pulmonary artery, producing post-stenotic dilatation — a consequence of the jet’s mechanical impact, not the obstruction itself, and one that’s only rarely of independent clinical significance (the exception being absent pulmonary valve syndrome, where massively dilated branch pulmonary arteries can compress the airways).

Clinical Findings

• Auscultation — a harsh systolic ejection murmur at the second left intercostal space, with a systolic ejection click that characteristically becomes softer with inspiration and louder with expiration — the opposite of the respiratory behavior most right-sided sounds show, and worth remembering precisely because it’s counterintuitive. A palpable thrill at the left upper sternal border and a faint or delayed P2 are also typical.
• ECG — right ventricular hypertrophy and right atrial enlargement.
• Chest X-ray — cardiomegaly from RV/RA enlargement, with post-stenotic main pulmonary artery dilatation.

Echocardiographic Findings

The pulmonary valve’s anatomy and physiology are well defined by 2D and Doppler imaging, and the RVOT can generally be assessed by echocardiography alone — other imaging is rarely needed.

Key Elements to Assess

• Valve morphology: leaflet number, mobility, and thickness; confirm the site of stenosis is at the valve.
• Additional levels of obstruction: infundibular and supravalvar.
• Diameters and z-scores: the pulmonary valve annulus (which helps catheterization planning), the sinotubular junction (for supravalvar stenosis), and the main and branch pulmonary arteries (for associated dilation).
• Gradients: Doppler-estimated peak and mean gradients across the valve from several views — CW Doppler for severity, PW Doppler for location — plus the Doppler envelope shape, and a check against the RV pressure estimated from the tricuspid regurgitation jet.
• Pulmonary regurgitation: its location and severity.
• The right heart: RV size, systolic and diastolic function, and hypertrophy; the tricuspid valve (annulus z-score, morphology, stenosis, regurgitation); right atrial and IVC size; and IVC and hepatic vein flow, looking for A-wave reversal.
• The atrial septum and ductus: measure any atrial defect and its shunt direction, and check for a PDA (size, direction, velocity) — both matter most in the neonate.

A View-by-View Approach

• Parasternal short-axis view at the base of the heart shows the valve in its longitudinal axis.
• Parasternal long-axis view, tilted toward the patient’s left shoulder, also brings the pulmonary valve into view, where thickened or doming leaflets and the dilated main pulmonary artery can be seen.
• Subxiphoid short-axis and right anterior oblique views are an excellent opportunity to define the valve morphology and assess additional levels of obstruction — a thickened dysplastic valve with RV hypertrophy is well seen here.
• Apical four-chamber view, adapted in infants and young children by sweeping anteriorly and clockwise so it includes the pulmonary valve and subvalvar region.
• High left parasternal view for a cross-sectional (en face) image of the valve: visualize the aortic valve in short-axis, then rotate the transducer clockwise about 10–20°. 3D imaging can also show the valve en face in about 60–70% of patients, though its incremental benefit hasn’t been established.
• Suprasternal and parasternal views for the post-stenotic main and branch pulmonary artery dilation, which should be measured — it’s only rarely clinically relevant (absent pulmonary valve syndrome being the exception).

What the Valve Looks Like

Assess leaflet number, mobility, and thickness. Smooth, domed valves typically respond well to balloon dilation, with the fused commissures tearing or disrupting; dysplastic, trileaflet valves often need surgery — so the morphology on echo directly guides treatment. Careful inspection is needed to tell a doming pulmonary valve from a discrete supravalvar stenosis — a membrane or a narrowing at the sinotubular junction — and in some cases the distinction is genuinely difficult.

Doppler Assessment

Color flow Doppler localizes the turbulent jet and helps align the CW Doppler beam. PW Doppler sampling systematically through the RVOT localizes the level of obstruction — subinfundibular, infundibular, valvular, or main/branch pulmonary artery — since treatment differs by level. The continuity equation can be used to calculate valve area, and pulmonary regurgitation should be assessed alongside stenosis.

• Use the simplified Bernoulli equation (gradient = 4 × velocity²), which is most accurate in discrete stenosis and less reliable with long-segment stenosis or multiple levels of obstruction in series.
• Align the beam with flow. Doppler underestimates catheter gradients when the beam diverges from the direction of flow by more than about 20%. Line the sample volume up parallel to flow with the help of color, in several views — parasternal short-axis, subxiphoid, and modified five-chamber.
• Measure both peak instantaneous and mean gradients. Doppler peak instantaneous gradients are often higher than the peak-to-peak gradient at catheterization, while mean Doppler gradients may predict catheter peak-to-peak gradients more accurately — so recording both is recommended.
• Read the shape of the envelope. Obstruction at the valve peaks in early systole, whereas dynamic subvalvar obstruction has a “dagger” shape, peaking at end-systole. Dynamic obstruction can increase markedly right after balloon valvuloplasty and reduce cardiac output, so the RVOT should be reassessed after the procedure.

Standard severity thresholds, by peak instantaneous gradient (equivalently, peak jet velocity):

Severity	Peak gradient	Peak velocity
Mild	Under 36 mmHg	Under 3 m/s
Moderate	36–64 mmHg	3–4 m/s
Severe	Over 64 mmHg	Over 4 m/s

These are the guideline-consistent cutoffs worth anchoring to. Watch specifically for a “50–75 mmHg moderate” range sometimes seen in older or informal references — it leaves an unaccounted gap between 36 and 50 mmHg and doesn’t reflect the standard classification above.

Critical Stenosis in the Neonate

Severe and critical PS in a neonate produces systemic or suprasystemic RV pressure. Critical stenosis is when the RV can’t maintain systemic saturations above 90% without a PDA: it can’t eject the whole systemic venous return, so deoxygenated blood crosses the PFO into the left atrium, and pulmonary blood flow comes to depend on left-to-right shunting across the PDA. Echo should therefore measure any atrial defect and show the direction of the shunt (right-to-left across the atrial septum is the hallmark), and check the PDA. Marked RV hypertrophy follows, and infundibular hypertrophy can add an anatomic or dynamic subvalvar component. After valvuloplasty, a “circular shunt” — blood recirculating through the PDA and back to the pulmonary artery — can cause poor systemic output and must be excluded in any patient with metabolic acidosis or cyanosis afterward.

Functional pulmonary atresia is a structurally normal valve that doesn’t open because of high postnatal pulmonary vascular resistance and an RV that can’t eject — usually with severe tricuspid regurgitation (Ebstein anomaly, dysplastic tricuspid valve) or RV myocardial disease. It matters because management differs entirely. Clues: well-formed but closed leaflets and a normal-sized annulus, subsystemic-to-suprasystemic RV pressure by the TR jet, and continuous pulmonary insufficiency, which can be diagnostic — though its absence doesn’t rule it out. See Ebstein’s Anomaly. As pulmonary vascular resistance falls and the RV recovers, a normal valve begins to open, whereas an abnormal valve’s gradient simply rises.

How to Diagnose It: A Practical Sequence

1. Find the valve on parasternal short-axis at the base and on long-axis tilted toward the left shoulder; look at leaflet number, thickness, and motion.
2. Classify the substrate: thin, domed, fused leaflets (doming) versus thickened, restricted, dysplastic leaflets — which predicts balloon versus surgical treatment.
3. Confirm the level. Use PW Doppler from within the RV to the branch pulmonary arteries, and the subxiphoid views, to show the obstruction is at the valve and to exclude infundibular, supravalvar, and branch stenosis.
4. Measure the gradient properly: CW Doppler aligned with flow in multiple views, both peak and mean, and cross- check with the TR-derived RV pressure.
5. Ask whether the gradient is trustworthy. Severe TR, RV dysfunction, pulmonary hypertension, or a large PDA can all lower or mask it.
6. Measure the annulus and pulmonary arteries (z-scores), and note post-stenotic dilation.
7. Assess the right heart: RV hypertrophy and function, tricuspid valve, right atrium, hepatic vein flow.
8. Check for a shunt — atrial septum (right-to-left flow means high right-sided pressure) and PDA — and for associated defects.
9. In a neonate, decide whether it is critical or functional atresia before anyone goes to the cath lab.

Pitfalls

• Flow-dependent gradients. Pressure gradients depend on both the effective orifice area and the flow rate, so anything that reduces flow across the valve underestimates obstruction — severe TR and RV dysfunction — and a pulmonary artery that’s hypertensive or has a large PDA raises the distal pressure and masks the true impediment. Severe stenosis with little or no gradient is possible; critical PS can sometimes be told from pulmonary atresia only by a trivial amount of pulmonary regurgitation.
• Before referral to the catheterization laboratory, make sure the pulmonary and tricuspid valves are adequate — convert measurements to z-scores, and use the tricuspid valve z-score as a surrogate for RV size, since RV volumes are very hard to quantify by echo.
• A subvalvar ridge can look valvar — see below.

Other Causes of Right Ventricular Outflow Tract Obstruction

Valvar stenosis is only one level at which the RVOT can be obstructed, and localizing the level correctly matters because each is treated differently. A quick guide:

Level	What it is	Echo clues
Valvar	Doming (fused) or dysplastic valve — this page	Thickened or doming leaflets in parasternal short-axis; peak gradient in early systole; post-stenotic dilation
Subvalvar	Discrete fibromuscular ridge or infundibular obstruction; double-chambered RV	Nonmobile thick ridge or anomalous muscle bundle below the valve; dagger-shaped Doppler; a high-pressure inlet chamber and a low-pressure infundibulum
Supravalvar / main PA	Discrete ridge or membrane, or a hypoplastic segment of the main PA	Membrane or narrowing just beyond the valve (well shown on TEE); PW Doppler places the obstruction above the valve
Branch pulmonary arteries	Discrete or long-segment narrowing, including from band migration after PA banding	Subtle on 2D — needs color Doppler; suprasternal and parasternal views; flow reversal
Absent pulmonary valve	Absent or rudimentary leaflets with an unguarded annulus	To-and-fro flow, dilated MPA and branches, an echo-bright fibrous ring
Multilevel (tetralogy of Fallot)	Infundibular narrowing from conal septal deviation, often with valvar and branch involvement	See Tetralogy of Fallot

• Subvalvar stenosis and double-chambered RV. Includes discrete fibromuscular ridges and infundibular stenosis as well as DCRV, in which anomalous muscle bundles divide the RV into a high-pressure inlet chamber and a low-pressure infundibular chamber. The obstruction usually isn’t present in the first months of life and tends to progress, so it’s more easily detected later. A central perimembranous VSD is the most common associated defect, and discrete subaortic stenosis commonly accompanies it. Echo shows a thick, nonmobile ridge at the proximal infundibular ostium or the anomalous bundles, best in subxiphoid short-axis, long-axis, and oblique views and in parasternal short-axis; the subxiphoid right anterior oblique view shows the RV inflow and outflow in the same plane, and on TEE the “RV inflow–outflow view” at about 45–80° is best. Color Doppler highlights the narrowing even when the gradient is mild. Because the VSD usually communicates with the high-pressure inlet chamber, the gradient across the VSD can be low despite real restriction, so check the LV outflow tract for subaortic stenosis and confirm the inlet pressure from the TR jet. A ridge just below the valve can be hard to tell from isolated valvar stenosis — pay attention to leaflet motion, fluttering, and early valve closure. In adults, subxiphoid images are harder to get and the parasternal approach works better; color Doppler and TEE help.
• Supravalvar (main pulmonary artery) stenosis. A discrete ridge or membrane just beyond the valve, at the mid main pulmonary artery, or near the bifurcation, or a diffusely hypoplastic segment. It’s associated with Williams, DiGeorge, Alagille, and Keutel syndromes and congenital rubella. It can also be acquired — for example, after pulmonary artery banding, where the band can migrate and encroach on the branch arteries, so regular imaging is needed.
• Branch pulmonary artery stenosis. Can be subtle: use both 2D and color Doppler, and set the color scale carefully. Image from parasternal and suprasternal windows (turn the suprasternal transducer toward 3 o’clock for the longest view). Color-derived diameters often overestimate the vessel, and flow reversal should be noted — a discrete narrowing hidden by systolic color flow can show up in diastole. In unilateral stenosis, flow is diverted to the normal side, so Doppler velocity can underestimate the obstruction, and the contralateral artery may show high flow instead. Recall the caution above: mild bilateral narrowing in a young infant is often physiologic.
• Absent pulmonary valve. Rudimentary or absent leaflets cause significant regurgitation with variable stenosis, and an “unguarded” outflow with to-and-fro flow. It’s most often seen with a tetralogy-type malalignment VSD, but can occur with an intact septum, where a PDA is typically present. The RV, MPA, and branch pulmonary arteries dilate — dilated branches may compress the airways. An echo-bright fibrous ring at the valve position is seen in parasternal and subxiphoid views. In the fetus it can be diagnosed from severe pulmonary regurgitation even before the arteries enlarge (around 22 weeks). See Pulmonary Regurgitation.

Treatment Considerations

• Balloon valvuloplasty is first-line for the typical doming, commissurally-fused valve, with generally excellent long-term results and low restenosis rates.
• Dysplastic valves (Noonan syndrome-associated or otherwise) respond less favorably to balloon dilation and more often require surgical valvotomy or, in severe cases, valve replacement.
• Associated lesions should be evaluated for — ASD and VSD in particular, and the level of obstruction should be clearly localized (valvular vs. subvalvular vs. supravalvular/peripheral) before deciding on an intervention strategy, since each level is addressed differently.
• Long-term RV function should be monitored, particularly in severe or long-standing cases, and after intervention, given the potential for residual pulmonary regurgitation to itself become a chronic volume load requiring follow-up — see Pulmonary Regurgitation for that broader picture.

Clinical Importance

Distinguishing valve morphology (doming/fused vs. dysplastic) and the precise level of obstruction matters as much as grading severity itself, since both directly determine which treatment is likely to succeed. See Right Ventricle Evaluation for how the resulting hypertrophy and function changes are assessed, and Atrial Septal Defect and Ventricular Septal Defect for the commonly co-associated shunt lesions worth screening for alongside PS. Pulmonary stenosis combined with a VSD, overriding aorta, and RV hypertrophy is the classic combination seen in Tetralogy of Fallot.